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Literature lacks publications about polar compounds content in infusion or guava leaves tea. Because of that, a comparison between
different times of infusion and a conventional ultrasound aqueous extract was carried out. Several polar compounds have been
identified by HPLC-ESI-MS and their antioxidant activity was evaluated by FRAP and ABTS assays. Four different classes of
phenolic compounds (gallic and ellagic acid derivatives, flavonols, flavanones, and flavan-3-ols) and some benzophenones were
determined. The quantification results reported that the order, in terms of concentration of the classes of polar compounds in all
samples, was flavonols > flavan-3-ols > gallic and ellagic acid derivatives > benzophenones > flavanones. As expected, the aqueous
extract obtained by sonication showed the highest content in the compounds studied. Significative differences were noticed about
the different times of infusion and five minutes was the optimal time to obtain the highest content in polar compounds using this
culinary method. All the identified compounds, except HHDP isomers and naringenin, were positively correlated with antioxidant
activity.
1. Introduction
The studies on antioxidant activity of plants have increased
dramatically in recent years, because they are identified
as natural antioxidant resources by traditional Chinese
medicine [1]. Medicinal plants have usually been applied to
control the blood glucose or reduce the diabetic complica-
tions; they have the potential to increase the life span and
quality of life in these patients [2]. The increasing prevalence
of type 2 diabetes mellitus and the negative clinical outcomes
observed with the commercially available antidiabetic drugs
have led to the investigation of new therapeutic approaches
focused on controlling postprandial glucose levels. The use
of carbohydrate digestive enzyme inhibitors from natural
resources could be a possible strategy to block dietary car-
bohydrate absorption with less adverse effects than synthetic
drugs. In fact, some authors [3] reported in vitro and in vivo
studies in relation to pancreatic alpha-amylase inhibitors of
plant origin and presented bioactive compounds of phenolic
nature that exhibit anti-amylase activity.
Guava leaves (Psidium guajava L.) are considered native
to Mexico but today they are extended throughout South
America, Europe, Africa, and Asia. Different studies consid-
ered these leaves as a promising source of phenolic com-
pounds for diabetes treatment [4]. Several authors noticed
that oral administration of capsules containing aqueous leaf
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Recently, Eidenberger and coworkers [6] investigated the
effect of extracts from Psidium guajava L. leaves, particu-
larly, the effects of main flavonol-glycoside components on
dipeptidyl-peptidase IV (DP-IV), a key enzyme of blood glu-
cose homoeostasis, and, finally, indicated that guava extract
has a potential to exert the effect observed in vitro also in
humans after oral administration.
In vivo experiments carried out by Cheng et al. [7]
reported that quercetin in the aqueous extract of guava leaves
promotes glucose uptake in liver cells and as a consequence
contributes to the alleviation of hypoglycemia in diabetes.
Usually, guava leaf tea was consumed after infusion; how-
ever, different infusion times were advice from production
company. Because of that, in the presentwork, the antioxidant
activities of infusions obtained at different infusion times
and conventional ultrasound aqueous extracts of guava leaves
were evaluated and compared in terms of their composition
in polar compounds.
2. Material and Methods
2.1. Chemicals. Double-deionised water with conductivity
lower than 18.2MΩ was obtained with a Milli-Q system
(Millipore, Bedford, MA, USA). Methanol LC-MS “optima”
grade and acetonitrile were obtained from Fisher Scien-
tific (Leicestershire, UK). Acetic acid and the standards
gallic acid, catechin, ellagic acid, naringenin, quercetin,
and rutin were all from Sigma-Aldrich (Steinheim, Ger-
many). The reagents used to measure the antioxidant capac-
ity, TPTZ (2,4,6-tripyridyl-S-triazine), Trolox (6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid), ABTS (2,2󸀠-
azinobis (3-ethylbenzothiazoline-6-sulfonate)), potassium
persulfate, and ferric sulfate, were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Sodium acetate, ferric chlo-
ride, and hydrochloric acid were obtained from Panreac
(Barcelona, Spain).
2.2. Plant Material and Sample Preparation. Fresh guava
leaves were harvested in Motril, Spain (36∘44󸀠43󸀠󸀠N,
3∘31󸀠14󸀠󸀠O). They were middle age intense green leaves and
they were collected in February 2014. The environmental
conditions had mean max/min temperature of 18/10∘C,
precipitation of 0mm, and saturated light duration that
ranged from 9.55 to 10.50 h day−1.
The samples were air-dried and ground before the
analyses. Two different extraction methodologies, such as
ultrasound extraction and infusion, were carried out.
Conventional Ultrasound Extraction. 0.5 g of dry guava leaves
was extracted with 15mL of water (×3) using a sonicator
BransonB3510 for 10min at room temperature.Then, samples
were centrifuged for 15min at 6000 rpm using a centrifuge
to remove solids. The supernatants were pooled, evaporated,
and dissolved in 2mL of 50% methanol. This solution was
filtered through a 0.20 𝜇m syringe filter and kept at −20∘C in
amber bottles to avoid degradation until analysis.
Infusion Extraction. For the infusion, 1 g of dried guava leaves
and 50mL of boiling water were used. The extract was
prepared according to the method previously described by
Chen and Yen [8], where they prepared 5min infusion and
compared with infusion for 3 and 7min. After the extraction
by infusion for 3, 5, and 7min, the solution was raised to
50mL with water, filtered through a 0.20𝜇m syringe filter,
and kept at −20∘C in amber bottles to avoid degradation until
analysis.
All extractions were made in triplicate.
2.3. Trolox Equivalent Antioxidant Capacity (ABTS) Assay.
TheABTS assay, which measures the reduction of the radical
cation of 2,2󸀠-azinobis-(3-ethylbenzothiazoline-6-sulfonate)
(ABTS) by antioxidants, was performed by using a method
previously described by Laporta and coworkers [9]. Con-
cisely, ABTS radical cation was produced by reacting ABTS
stock solution with 2.45mMpotassium persulfate in the dark
at room temperature for 12–24 h before use. The absorbance
of ABTS radical cation was adjusted to 0.70 (±0.02) at
734 nm. A calibration curve was prepared with different
concentrations of Trolox (0–20𝜇M).
2.4. Ferric-Reducing Antioxidant Power (FRAP). The reduc-
ing power was evaluated according to the method validated
by Benzie and Strain [10]. Briefly, 300mM acetate buffer
(pH 3.6), 10mM TPTZ in 40mM HCl, and 20mM aqueous
FeCl
3
were prepared andmixed (10 : 1 : 1), to obtain the FRAP
reagent. The FRAP reagent was warmed to 37∘C, before
reading its absorbance. Then, the samples were added. The
change in absorbance (593 nm) between the samples and the
blank was related to the absorbance of an aqueous solution of
known Fe(II) concentration, prepared for calibration.
2.5. HPLC-ESI-MS Analysis. Phenolic and other polar com-
pounds in the extracts obtained from guava leaves were iden-
tified using a method introduced by Chang et al. [11], with
slight modifications. Briefly, HPLC analyses were performed
using a HP 1100 Series instrument (Hewlett Packard, Wilm-
ington, DE, USA) equipped with a binary pump delivery
system, a degasser (model G1322A), an autosampler (Auto-
matic Liquid Sampler, ALS,model G1312A), aHPdiode-array
UV-VIS detector (DAD, model G1315A), and a quadrupole
HP-Mass Spectrometer Detector (MSD, model G1946A);
integration and data elaboration were performed using
Chemstation software (Hewlett Packard). A Phenomenex
Luna C18 analytical column (150mm × 2.0mm, particle size
3 𝜇m) (Phenomenex Inc., Torrance, CA, USA) was used for
polar compounds separation. All analyses were carried out
at room temperature using the gradient proposed by Chang
et al. [11]. MS analysis was carried out using an electrospray
ionization (ESI) interface in negative ionization mode at
the following conditions: drying gas flow (N
2
), 9.0 L/min;
nebulizer pressure, 50 psi; gas drying temperature, 350∘C;
capillary voltage, 3500V; and fragmentor voltage and scan
range, 100V andm/z 50–1000, respectively.
Phenolic standards of interest such as gallic acid, catechin,
ellagic acid, naringenin, and rutin were used for quantifi-
cation of phenolic compounds in guava leaf extracts. The
identified compounds were quantified on the basis of their
peak area and compared with calibration curves obtained
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with the corresponding standards and then expressed as 𝜇g/g
of extract.
2.6. Statistical Analysis. The results reported in this study
are the averages of three repetitions (𝑛 = 3). Fisher’s
least significance difference (LSD) test and Pearson’s linear
correlations, both at 𝑃 < 0.05, were evaluated using Statistica
6.0 (2001, StatSoft, Tulsa, OK).
3. Results and Discussion
3.1. Identification of Polar Compounds. Phenolic and other
polar compounds were identified by their elution order,
UV/vis spectra, and MS characteristics, compared with
reported literature values, and by coinjection with available
standards (Table 1).
About phenolic compounds, four different classes identi-
fied as gallic and ellagic acid derivatives, flavonols, flavanones,
and flavan-3-ols were determined.
Thirteen gallic and ellagic acid derivatives were deter-
mined. Three compounds (1, 2, and 3) with molecular ion
at m/z 481 and fragment at m/z 301 were identified as hex-
ahydroxydiphenic acid (HHDP) glucose and its presence in
guava was previously reported by Okuda and coworkers [12].
Gallic acid (compound 4) was identified according to its MS
data (m/z 169 andm/z 125) and by coelution with a chemical
standard. Two compounds (6 and 11) with [M–H]− at m/z
783 and two fragments at m/z 481 and 301 corresponding to
loss of ellagic acid were detected. This fragmentation pattern
was assigned to pedunculagin/casuariin compounds; these
compounds were described in guava leaves by Okuda et al.
[12].
Two compounds (10 and 12) with molecular ion at m/z
951 and fragments at m/z 783 and 481 were also determined.
These compounds were identified as geraniin isomers [13].
Two compounds (15 and 18) showing significant [M–H]−
signals at m/z 785 with fragment ions at m/z 615 and at m/z
301were found.This fragmentation pattern corresponded to a
digalloyl-HHDP-glucose structure, probably tellimagrandin
I isomer. This compound was previously detected in guava
leaves by Okuda et al. [12]. Compound 17 atm/z 935 reported
a fragment ion at m/z 783; this fragmentation pattern was
assigned to casuarinin/casuarictin and this compound was
described in guava tea by Yamanaka and coworkers [13].
Compound 30 was identified as ellagic acid due its coelution
with commercial standard. Finally, guavin B (compound 46)
that reported a molecular ion at m/z 693 was identified
according to Okuda et al. [14].
Moreover, ten flavan-3-ol derivatives were determined.
Compounds 5 and 42 showed amolecular ion atm/z 609 and
three fragments atm/z 441, 423, and 305 (gallocatechin unit);
these compounds were identified as prodelphinidin B2 and
its isomer and their presence in guava leaves was noticed by
Qa’Dan et al. [15].
Compounds 7 and 9 showed a molecular ion at m/z 593
and two fragments atm/z 425 and 407. According to Qa’Dan
et al. [15], these compounds were identified as prodelphinidin
dimer (4𝛼-8).
Two compounds (8 and 19) with [M–H]− at m/z 305
and fragment ions at m/z 221 and 179 were identified as
gallocatechin isomers and their presence in guava leaves was
reported by Qa’Dan et al. [15]. Three procyanidin dimers
([M–H]− atm/z 577) were also described (compounds 13, 14,
and 21).
Catechin compound (16) was identified by mass spectra
data elaboration and coelution with a commercial standard.
The flavonols were themost representative phenolic com-
pounds; in fact, eighteen flavonol-derivatives were identified.
Four compounds (compounds 20, 24, 27, and 29) reported a
molecular ion atm/z 449 and twomajor fragments atm/z 316
and 317. According to Chang et al. [11], these compounds were
identified as myricetin-arabinoside/xylopyranoside isomers.
Two flavonol compounds (compounds 22 and 23) with
molecular ion at m/z 479 and fragments at m/z 317 and
316 were identified as myricetin-hexoside isomers [11]. Two
compounds (25 and 26) corresponding to [M–H]− signals at
m/z 615 were also detected. Based on their molecular weight
and the presence of two fragments at m/z 463 and 301, they
were assigned to quercetin-galloylhexoside isomers and their
presence in guava leaves was reported by Park et al. [16].
Two compounds at m/z 301 were detected (28 and 47);
moreover, they showed the same fragment ion at m/z 151.
Quercetin standard solution was injected and because of that
compound 28 was assigned to morin and compound 47 was
assigned to quercetin; their presence in guava leaves was
reported by several authors [11, 17].
Compounds detected at m/z 463 (31 and 33) with
fragment ion at m/z 301 corresponded to hyperin and
isoquercitrin, respectively. They have previously been found
in leaves of guava by Eidenberger et al. [6].
Quercetin glucuronide (32) withmolecular ion atm/z 477
and fragment ions atm/z 433 and 301was identified according
to Chang et al. [11].
Three compounds (34, 35, and 37) reported the same
molecular ion (m/z 433) and a fragment ion atm/z 301 (corre-
sponding to quercetin aglycone); according to their retention
times, they were identified as reynoutrin, guajaverin, and
avicularin as reported by Chang et al. [11].
Quercitrin (38) was identified at m/z 447 and fragment
ionm/z 300, according to Park et al. [16].
A flavanone compound, namely, naringenin (m/z 271),
was detected and identified by analyzing themass spectra and
by coelution with a chemical standard [18]. Compound 39
withm/z 585 was identified as guavinoside C [19].
Six benzophenone compounds were also determined in
guava leaves sample.The [M–H]− ion atm/z 543 revealed the
presence of two compounds, namely, guavinoside A isomers;
their presence in guava leaves was noticed by Matsuzaki and
coworkers [19].
Finally, four compounds with m/z 571 (40, 43, 44, and
45) were identified as guavinoside B isomers according to
Matsuzaki et al. [19].
3.2. Quantification of Polar Compounds. Comparison
between different times of infusion and a conventional
ultrasound aqueous extract was carried out due to several
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Table 1: Identification of polar compounds in guava leaves by HPLC-DAD-ESI-MS.
Number Compounds 𝜆max (nm) [M–H]
− Fragments
1 HHDP glucose isomer 290 481 301
2 HHDP glucose isomer 290 481 301
3 HHDP glucose isomer 290 481 301
4 Gallic acid 272, 225 169 125
5 Prodelphinidin B2 isomer 280, 360 609 423, 441, 305
6 Pedunculagin/casuariin isomer 253, 377 783 481, 301
7 Prodelphinidin dimer isomer 280, 340 593 407, 425
8 Gallocatechin 236, 270sh 305 179, 221
9 Prodelphinidin dimer isomer 280, 340 593 407, 425
10 Geraniin isomer 270 951 783, 481, 301
11 Pedunculagin/casuariin isomer 253, 377 783 481, 301
12 Geraniin isomer 270 951 783, 481
13 Procyanidin B isomer 278, 234 577 289
14 Procyanidin B isomer 278, 235 577 289
15 Tellimagrandin I isomer 279, 340 785 615, 301
16 Catechin 236, 281 289 245, 205, 179
17 Casuarinin/casuarictin isomer 238, 275sh 935 783
18 Tellimagrandin I isomer 277, 338 785 615, 301
19 Gallocatechin 236, 270sh 305 179, 221
20 Myricetin-arabinoside/xylopyranoside isomer 264, 231sh, 356 449 316, 317
21 Procyanidin B isomer 2 268, 350 577 425, 289
22 Myricetin hexoside isomer 261, 231sh, 358 479 316, 317
23 Myricetin hexoside isomer 264, 235sh, 356 479 316, 317
24 Myricetin-arabinoside/xylopyranoside isomer 264, 231sh, 356 449 316, 317
25 Quercetin-galloylhexoside isomer 268, 350 615 463, 301
26 Quercetin-galloylhexoside isomer 280, 345 615 463, 301
27 Myricetin-arabinoside/xylopyranoside isomer 256, 234sh, 356 449 316, 317
28 Morin 232sh, 257, 374 301 151
29 Myricetin-arabinoside/xylopyranoside isomer 257, 231sh, 356 449 316, 317
30 Ellagic acid 254, 370 301 257, 185
31 Hyperin 259, 355, 235sh 463 301
32 Quercetin glucuronide 265, 355, 233sh 477 301, 433
33 Isoquercitrin 258, 355, 235sh 463 301
34 Reynoutrin 258, 356, 231sh 433 301
35 Guajaverin 257, 356, 231sh 433 301
36 Guavinoside A 218, 288 543 —
37 Avicularin 257, 355, 231sh 433 301
38 Quercitrin 264, 353 447 300
39 Guavinoside C 211, 265, 355 585 —
40 Guavinoside B 218, 283 571 —
41 Guavinoside A isomer 218, 288 543 —
42 Prodelphinidin B2 isomer 2 282, 340 609 423, 441, 305
43 Guavinoside B isomer 218, 283 571 —
44 Guavinoside B isomer 218, 283 571 —
45 Guavinoside B isomer 218, 283 571 —
46 Guavin B 208, 221, 283 693 —
47 Quercetin 232sh, 257, 374 301 151
48 Naringenin 280 271 —
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publications about phenolic and other polar compounds
content in infusion or guava leaves tea.
Quantification of polar compounds was performed by
preparing five calibration curves with the standards available:
gallic acid, catechin, ellagic acid, naringenin, and rutin. For
those with no commercial standard available, quantification
was carried out comparing with compounds bearing similar
structures.
It is important to underline that the quantification results
reported that the order, in terms of concentration of the
families of polar compounds in all samples, decreased in the
following order: flavonols > flavan-3-ols > gallic and ellagic
derivatives > benzophenones > flavanones.
In general, the results given in Table 2 show that the
concentration of each compound is greater in the ultrasound
aqueous extract (AE), except the compounds identified as
HHDP glucose that was higher in the infusion of 3min
(I3) and in the 5min (I5) samples and naringenin, which
presented the largest concentration in I3. Similar results were
obtained by Nantitanon and coworkers [20] using ethanol as
extraction solvent. In fact, they extracted the guava leaves
by maceration and ultrasounds, and the highest recovery of
phenolic compounds was obtained by sonication.
The higher extraction of HHDP and naringenin in some
infusions than ultrasound extraction could be justified by the
temperature that has been reached during the two extraction
methodologies. As reported by Zhang and coworkers [21] the
solubility of naringenin gradually increases as the tempera-
ture increases; based on these results, it is expected to obtain
lower extraction of these compounds during ultrasound
extraction instead of that of infusion. This hypothesis can
be confirmed with the results obtained by Wen et al. [22]
that noticed that naringenin is insoluble in water at room
temperature.
However, naringenin content in infusion samples
reported a decreasing trend when increasing the time of
infusion; these results should be attributed to a degradation of
this compound when the thermal treatment was prolonged.
To the best of our knowledge, there is no literature about
the water solubility and the effect of temperature on HHDP
compound. Nevertheless, taking into account the results
reported in Table 2, a similar trend to the one reported for
naringenin compound could be supposed for HHDP.
Flavan-3-ols, gallic and ellagic acid derivatives, ben-
zophenones, and flavonols in the ultrasound aqueous extract
were from 3 to 5 times more concentrated than leaves
infusions. Compared to the ultrasound aqueous extract (AE)
and infusion of 7min (I7) samples, naringenin was 1.5 and 1.7
times higher in the infusion of 3min (I3) and in the 5min (I5)
samples, respectively.
Flavonols represent about 50 percent of total polar com-
pounds in each sample. Avicularin and guajaverin were the
major flavonol components and their concentrations varied
from 13.7 to 3.2mg/g and from 12.8 to 2.7mg/g, respectively.
Similar trend was showed by Chang et al. [11]. Morin was also
found in high concentration with a range that varies from 3.0
to 8.4mg/g in I7 and AE sample, respectively. Other flavonol
compounds presented in all samples in higher quantities and
in the same order of magnitude were hyperin, quercitrin,
reynoutrin, and isoquercitrin. Myricetin-arabinoside was
detected in all samples, but it was quantified only in AE
sample; instead, quercetin was only detected and quantified
in the AE sample. These data could promote the use of guava
leaves extract for nutraceutical scopes because, as reported by
Wang et al. [23],myricetin and quercetin have high inhibitory
activities against some enzymes that are involved in diabetes.
Guavinoside C was quantified in ultrasound aqueous extract;
it was identified in infusion samples, but its content was lower
than LOQ.
The second class of polar compounds was represented
by flavan-3-ols, which correspond to 26–30% of total polar
compounds. Procyanidin was the first polar compound and
its amounts ranged from 6.1 to 17.7mg/g. Catechin was the
second flavan-3-ol ranging between 5.1 and 12.9mg/g.
Two epigallocatechin isomers and prodelphinidin dimer
were the third flavan-3-ols and their amounts were about 5.4–
5.9mg/g.
Gallic and ellagic acid derivatives account for 20% of
the total concentration of polar compounds in each sam-
ple. In this case, ultrasound aqueous extract and infusions
reported different extraction power. Effectively, ultrasound
aqueous extract showed casuarinin/casuarictin as first ellagic
acid derivative (8.7mg/g); on the contrary, infusion samples
reported HHDP glucose compounds in the highest amounts
(2.0–2.3mg/g). Benzophenones were 2–4% of total polar
compounds. Guavinoside A was the first benzophenone and
it was represented by two isomers. Finally, four guavinoside
B isomers were also detected in the extract, but only one was
quantified; their content in infusion samples was less than
LOQ or, in some cases, they were not detected.
At last, a flavanone, namely, naringenin was presented
in all samples; I3 sample showed the higher content; on the
contrary, aqueous extract and I7 samples reported the lowest
quantities.
3.3. Comparison between Phenolic Content and Antioxidant
Activity. As shown in Figure 1, the amount of total polar
compounds is significantly higher in the ultrasound aqueous
extract than in the infusions. Comparing the results obtained
for the infusions, the quantity of these compounds is quite
higher for I5 than for the others, I3 and I7. In fact, I3 sample
reported a lower content probably due to an incomplete
extraction of polar compounds; instead, I7 sample showed
lower amounts, probably due to a degradation of these
compounds during maceration.
To evaluate the antioxidant activity of the extract and
to corroborate the correlation between phenolic content and
antioxidant activity, two different assays were developed:
TEAC evaluated by ABTS∙+ test and FRAP.
The choice of these two methods was assessed based on
their different mechanisms: the radical scavenging capacity
demonstrated by ABTS and ferric reducing capacities evalu-
able by FRAP method. Moreover, the results obtained by
Thaipong et al. [24] demonstrated that ABTS and FRAP
reported higher correlation with total phenolic content in
guava fruit compared to other antioxidant activity assays.
Total polar compounds by HPLC are in concordance
with the values obtained for the FRAP and ABTS assays
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Table 2: Quantification (mean ± SD, n = 3) of the compounds identified in guava leaves infusions and ultrasound aqueous extract.
Number Compounds Quantification (𝜇g analyte/g leaves)
AE I3 I5 I7
1 HHDP glucose isomer 1146 ± 34c 2256 ± 37a 2253 ± 27a 2021 ± 67b
2 HHDP glucose isomer 228 ± 40b 441 ± 72a 368 ± 59a,b 397 ± 93a,b
3 HHDP glucose isomer 1424 ± 48c 1756 ± 39a 1762 ± 12a 1546 ± 27b
4 Gallic acid 719 ± 33a 240 ± 5b 260 ± 5b 254 ± 9b
5 Prodelphinidin B2 isomer 665 ± 55a 212 ± 11b 220 ± 12b 126 ± 8c
6 Pedunculagin/casuariin isomer 2405 ± 38a 573 ± 14c 688 ± 5b 533 ± 6c
7 Prodelphinidin dimer isomer 1768 ± 90a 444 ± 26b 467 ± 20b 335 ± 11b
8 Gallocatechin 5887 ± 273a 2419 ± 19b 2301 ± 43b,c 1960 ± 77c
9 Prodelphinidin dimer isomer 5452 ± 308a 1526 ± 4b 1688 ± 40b 1309 ± 34b
10 Geraniin isomer 1396 ± 47a 304 ± 1b 318 ± 12b 201 ± 8c
11 Pedunculagin/casuariin isomer 2894 ± 46a 687 ± 9c 814 ± 19b 624 ± 6c
12 Geraniin isomer 2333 ± 160a 433 ± 26b 457 ± 8b 304 ± 3b
13 Procyanidin B isomer 17659 ± 785a 6703 ± 124b 7106 ± 51b 6105 ± 34b
14 Procyanidin B isomer 1751 ± 150a 398 ± 10b 413 ± 10b 321 ± 9b
15 Tellimagrandin I isomer 728 ± 26a 141 ± 2c 184 ± 5b 129 ± 2c
16 Catechin 12875 ± 705a 6127 ± 80b 5960 ± 19b 5192 ± 2b
17 Casuarinin/casuarictin isomer 8725 ± 216a 482 ± 1c 859 ± 21b 590 ± 17b,c
18 Tellimagrandin I isomer 1492 ± 46a 186 ± 6b,c 243 ± 9b 164 ± 3c
19 Gallocatechin 5866 ± 362a 2205 ± 134b,c 2446 ± 21b 1896 ± 13c
20 Myricetin-arabinoside/xylopyranoside isomer 608 ± 18a <LOQ <LOQ <LOQ
21 Procyanidin B isomer 2 1206 ± 56a 207 ± 14b,c 224 ± 7b 136 ± 6c
22 Myricetin hexoside isomer 1301 ± 44a <LOQ <LOQ <LOQ
23 Myricetin hexoside isomer 331 ± 2a 245 ± 2c 299 ± 3b 232 ± 4d
24 Myricetin-arabinoside/xylopyranoside isomer 639 ± 29a <LOQ <LOQ <LOQ
25 Quercetin-galloylhexoside isomer 566 ± 20a 148.3 ± 0.1b 171 ± 2b 149 ± 1b
26 Quercetin-galloylhexoside isomer 452 ± 15a 97.25 ± 0.02b 102.3 ± 0.4b 92.25 ± 0.07b
27 Myricetin-arabinoside/xylopyranoside isomer 592 ± 24a <LOQ <LOQ <LOQ
28 Morin 8377 ± 464a 3235 ± 53b,c 3676 ± 12b 3003 ± 18c
29 Myricetin-arabinoside/xylopyranoside isomer 986 ± 28a <LOQ <LOQ <LOQ
30 Ellagic acid 4338 ± 234a 1082 ± 16b 1367 ± 14b 1040 ± 9b
31 Hyperin 7798 ± 280a 2492 ± 6c 2891 ± 7b 2031 ± 18d
32 Quercetin glucuronide 2293 ± 91a 1249 ± 19c 1612 ± 40b 1132 ± 7c
33 Isoquercitrin 4408 ± 182a 1111 ± 19b,c 1306 ± 5b 996 ± 3c
34 Reynoutrin 5849 ± 173a 1386 ± 21b,c 1611 ± 20b 1229 ± 9c
35 Guajaverin 12843 ± 421a 3169 ± 40b,c 3595 ± 4b 2713 ± 36c
36 Guavinoside A 1920 ± 40a 453 ± 3c 522 ± 1b 413 ± 2c
37 Avicularin 13666 ± 421a 3825 ± 48b 4183 ± 34b 3232 ± 25c
38 Quercitrin 6822 ± 274a 1825 ± 39b 2078 ± 24b 1705 ± 12b
39 Guavinoside C 2298 ± 40a <LOQ <LOQ <LOQ
40 Guavinoside B 1456 ± 34a 370 ± 3c 423 ± 4b 328.6 ± 0.1c
41 Guavinoside A isomer 558 ± 4a 177 ± 1b 160 ± 4c 140.0 ± 0.3d
42 Prodelphinidin B2 isomer 2 <LOQ <LOQ <LOQ <LOQ
43 Guavinoside B isomer <LOQ <LOQ <LOQ <LOQ
44 Guavinoside B isomer <LOQ nd nd nd
45 Guavinoside B isomer <LOQ nd nd nd
46 Guavin B 460 ± 6a 34 ± 1b 32.2 ± 0.2b 20 ± 1c
47 Quercetin 408 ± 18a nd nd nd
48 Naringenin 538 ± 14c 941 ± 3a 815 ± 24b 558 ± 9c
n.d.: not detected; AE: aqueous extract obtained by ultrasound; I3, I5, and I7: infusion obtained at 3, 5, and 7 minutes of infusion time, respectively.
The different letter in the same line means that the compounds are significantly different (P ≤ 0.05).
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Figure 1: Total content (mg/g) of total polar compounds by HPLC in analysed samples.
Table 3: Comparison between total polar compound (mg/g) determined by HPLC and antioxidant activity evaluated by FRAP (𝜇Mof FeSO4
equivalents/mg) and ABTS (𝜇M of Trolox equivalents/mg).
Sample TPC by HPLC FRAP ABTS
AE 157 ± 6.0a 3026.7 ± 586.4a 1127.6 ± 69.0a
I3 49.6 ± 0.5c 314.2 ± 15.1b 155.7 ± 1.1b
I5 53.8 ± 0.2b 285.3 ± 7.0b 217.6 ± 19.2b
I7 43.1 ± 0.4d 285.7 ± 7.0b 178.2 ± 1.3b
Means in the same column with different letter are significantly different (P < 0.05).
(Table 3). Besides, the reducing power and radical scavenging
capacity displayed a significative difference between the
samples obtained by infusion and the ultrasound aqueous
extract. Positive correlations with R = 0.9883 and 𝑃 < 0.001
and R = 0.9973 and 𝑃 < 0.001 were noticed between total
polar compounds content and FRAP and ABTS, respectively.
FRAP and ABTS did not report significative differences
(𝑃 < 0.05) among infusion samples; however, ultrasound
aqueous extract values were higher than infusions values.
Moreover, a simple linear regression analysis was carried
out to compare the correlation between all compounds
identified and the antioxidant activity (Table 4).
Most of the polar compounds were highly correlated with
FRAP assay (R = 0.98; 𝑃 < 0.001) except compounds 10, 30,
and 32 that reported an𝑅 value ranging between 0.96 and 0.97
(𝑃 < 0.001). Compound 23 showed a lower correlation (R =
0.76; 𝑃 < 0.05). HHDP glucose isomers resulted in inverse
correlation with FRAP assay. Moreover, naringenin did not
show any correlation.
ABTS assay confirmed data reported by FRAP assay; in
fact, the two antioxidant assays showed a good correlation
between them that reported an R value of 0.9916 and 𝑃 <
0.0001. These results agreed with the data reported by
Thaipong et al. [24].
4. Conclusions
Several polar compounds have been identified and quantified
in guava leaves extracts (ultrasound aqueous extract and
infusions). According to the amount of polar compounds
and also the FRAP and ABTS assays, the water ultrasound
assisted extraction provided better results than the infusion.
Significative positive correlations R > 0.98 and 𝑃 < 0.001
were detected between total polar content and antioxi-
dant activity assays. Moreover, positive correlation was also
detected for single compounds, except for HHDP and narin-
genin.
The results suggested that aqueous ultrasound extract can
represent a valuable strategy to obtain nutraceuticals using a
green technology. About infusions, the 5-minute infusion is
advisable for guava leaves culinary uses because of reported
higher polar compounds content.
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Table 4: Correlation between the antioxidant activity and polar compounds.
Compounds FRAP ABTS
𝑅 value 𝑃 value 𝑅 value 𝑃 value
1 HHDP glucose isomer −0.9644 ∗ ∗ ∗ −0.9721 ∗ ∗ ∗
2 HHDP glucose isomer −0.8199 ∗ −0.8321 ∗
3 HHDP glucose isomer −0.7507 ∗ −0.7700 ∗
4 Gallic acid 0.992 ∗ ∗ ∗ 0.9993 ∗ ∗ ∗
5 Prodelphinidin B2 isomer 0.9817 ∗ ∗ ∗ 0.9845 ∗ ∗ ∗
6 Pedunculagin/casuariin isomer 0.9849 ∗ ∗ ∗ 0.9980 ∗ ∗ ∗
7 Prodelphinidin dimer isomer 0.9895 ∗ ∗ ∗ 0.9962 ∗ ∗ ∗
8 Gallocatechin 0.9887 ∗ ∗ ∗ 0.9922 ∗ ∗ ∗
9 Prodelphinidin dimer isomer 0.9909 ∗ ∗ ∗ 0.9977 ∗ ∗ ∗
10 Geraniin isomer 0.9747 ∗ ∗ ∗ 0.9911 ∗ ∗ ∗
11 Pedunculagin/casuariin isomer 0.985 ∗ ∗ ∗ 0.9979 ∗ ∗ ∗
12 Geraniin isomer 0.9922 ∗ ∗ ∗ 0.9911 ∗ ∗ ∗
13 Procyanidin B isomer 0.9907 ∗ ∗ ∗ 0.9978 ∗ ∗ ∗
14 Procyanidin B isomer 0.9949 ∗ ∗ ∗ 0.9973 ∗ ∗ ∗
15 Tellimagrandin I isomer 0.987 ∗ ∗ ∗ 0.9985 ∗ ∗ ∗
16 Catechin 0.99 ∗ ∗ ∗ 0.9916 ∗ ∗ ∗
17 Casuarinin/casuarictin isomer 0.9874 ∗ ∗ ∗ 0.9990 ∗ ∗ ∗
18 Tellimagrandin I isomer 0.9881 ∗ ∗ ∗ 0.9989 ∗ ∗ ∗
19 Gallocatechin 0.9881 ∗ ∗ ∗ 0.994 ∗ ∗ ∗
20 Myricetin-arabinoside/xylopyranoside isomer 0.9889 ∗ ∗ ∗ 0.9978 ∗ ∗ ∗
21 Procyanidin B isomer 2 0.9891 ∗ ∗ ∗ 0.9967 ∗ ∗ ∗
22 Myricetin hexoside isomer 0.9893 ∗ ∗ ∗ 0.9979 ∗ ∗ ∗
23 Myricetin hexoside isomer 0.7694 ∗ 0.8073 ∗
24 Myricetin-arabinoside/xylopyranoside isomer 0.9907 ∗ ∗ ∗ 0.9981 ∗ ∗ ∗
25 Quercetin-galloylhexoside isomer 0.9893 ∗ ∗ ∗ 0.9994 ∗ ∗ ∗
26 Quercetin-galloylhexoside isomer 0.99 ∗ ∗ ∗ 0.9986 ∗ ∗ ∗
27 Myricetin-arabinoside/xylopyranoside isomer 0.9901 ∗ ∗ ∗ 0.9980 ∗ ∗ ∗
28 Morin 0.9889 ∗ ∗ ∗ 0.9967 ∗ ∗ ∗
29 Myricetin-arabinoside/xylopyranoside isomer 0.9887 ∗ ∗ ∗ 0.9977 ∗ ∗ ∗
30 Ellagic acid 0.9684 ∗ ∗ ∗ 0.9915 ∗ ∗ ∗
31 Hyperin 0.983 ∗ ∗ ∗ 0.9938 ∗ ∗ ∗
32 Quercetin glucuronide 0.9622 ∗ ∗ ∗ 0.9794 ∗ ∗ ∗
33 Isoquercitrin 0.9887 ∗ ∗ ∗ 0.9983 ∗ ∗ ∗
34 Reynoutrin 0.9874 ∗ ∗ ∗ 0.9982 ∗ ∗ ∗
35 Guajaverin 0.9878 ∗ ∗ ∗ 0.9978 ∗ ∗ ∗
36 Guavinoside A 0.9866 ∗ ∗ ∗ 0.9982 ∗ ∗ ∗
37 Avicularin 0.9874 ∗ ∗ ∗ 0.9970 ∗ ∗ ∗
38 Quercitrin 0.9897 ∗ ∗ ∗ 0.9989 ∗ ∗ ∗
39 Guavinoside C 0.9873 ∗ ∗ ∗ 0.9974 ∗ ∗ ∗
40 Guavinoside B 0.9864 ∗ ∗ ∗ 0.9979 ∗ ∗ ∗
41 Guavinoside A isomer 0.9842 ∗ ∗ ∗ 0.9928 ∗ ∗ ∗
46 Guavin B 0.9865 ∗ ∗ ∗ 0.9968 ∗ ∗ ∗
47 Quercetin 0.9906 ∗ ∗ ∗ 0.9981 ∗ ∗ ∗
48 Naringenin −0.5619 NC −0.5855 NC
TPC by HPLC 0.9883 ∗ ∗ ∗ 0.9973 ∗ ∗ ∗
∗∗∗
𝑃 < 0.001; ∗𝑃 < 0.05; NC: not correlated.
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